View in EDS HTML Full Text PDF Full Text

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.

Saved in:
Bibliographic Details
Title: Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.
Authors: Rugo HS; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA. hope.rugo@ucsf.edu., Campbell M; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Yau C; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Jo Chien A; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Isaacs C; Georgetown University, Washington, DC, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Han HS; Moffitt Cancer Center, Tampa, FL, USA., Buxton M; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Clennell JL; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Steeg K; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Singhrao R; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Matthews JB; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Perlmutter J; Gemini Group, Ann Arbor, MI, USA., Fraser Symmans W; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hylton NM; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., DeMichele AM; University of Pennsylvania, Philadelphia, PA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., Van't Veer LJ; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA., Berry DA; Berry Consultants, LLC, Houston, TX, USA., Esserman LJ; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 209 (3), pp. 487-492. Date of Electronic Publication: 2024 Dec 03.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39625569
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA. hope.rugo@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Campbell+M%22">Campbell M</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Jo+Chien+A%22">Jo Chien A</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Han+HS%22">Han HS</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Buxton+M%22">Buxton M</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Clennell+JL%22">Clennell JL</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Steeg+K%22">Steeg K</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Fraser+Symmans+W%22">Fraser Symmans W</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Van't+Veer+LJ%22">Van't Veer LJ</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; University of California San Francisco, Box 1710, San Francisco, CA, 94143, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Feb; Vol. 209 (3), pp. 487-492. <i>Date of Electronic Publication: </i>2024 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39625569
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-024-07555-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 487
    Titles:
      – TitleFull: Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Campbell M
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Jo Chien A
      – PersonEntity:
          Name:
            NameFull: Wallace AM
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Han HS
      – PersonEntity:
          Name:
            NameFull: Buxton M
      – PersonEntity:
          Name:
            NameFull: Clennell JL
      – PersonEntity:
          Name:
            NameFull: Asare SM
      – PersonEntity:
          Name:
            NameFull: Steeg K
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Singhrao R
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: Fraser Symmans W
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: DeMichele AM
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: Van't Veer LJ
      – PersonEntity:
          Name:
            NameFull: Berry DA
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 209
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1